The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 24, 2023
Filed:
Oct. 26, 2022
Applicants:
Ecofibre Usa Inc., Georgetown, KY (US);
The University of Newcastle, Callaghan, AU;
Inventors:
Alexandra M. Capano, Philadelphia, PA (US);
Pradeep Singh Tanwar, Fletcher, AU;
Alex Nance, Georgetown, KY (US);
Assignees:
Ecofibre USA Inc., Georgetown, KY (US);
The University of Newcastle, Callaghan, AU;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/05 (2006.01); A61K 36/185 (2006.01); A61P 35/00 (2006.01); A61K 31/015 (2006.01); A61K 31/045 (2006.01); A61K 31/216 (2006.01); A61K 31/352 (2006.01); A61K 31/355 (2006.01); A61K 31/7048 (2006.01); A61K 31/395 (2006.01); A61K 33/243 (2019.01); A61K 31/01 (2006.01); A61K 31/198 (2006.01); A61K 31/282 (2006.01); A61K 31/337 (2006.01); A61K 31/4745 (2006.01); A61K 31/513 (2006.01); A61K 31/519 (2006.01); A61K 31/675 (2006.01); A61K 31/704 (2006.01); A61K 31/7068 (2006.01); A61K 39/395 (2006.01);
U.S. Cl.
CPC ...
A61K 36/185 (2013.01); A61K 31/01 (2013.01); A61K 31/015 (2013.01); A61K 31/045 (2013.01); A61K 31/05 (2013.01); A61K 31/198 (2013.01); A61K 31/216 (2013.01); A61K 31/282 (2013.01); A61K 31/337 (2013.01); A61K 31/352 (2013.01); A61K 31/355 (2013.01); A61K 31/4745 (2013.01); A61K 31/513 (2013.01); A61K 31/519 (2013.01); A61K 31/5545 (2017.08); A61K 31/675 (2013.01); A61K 31/704 (2013.01); A61K 31/7048 (2013.01); A61K 31/7068 (2013.01); A61K 33/243 (2019.01); A61K 39/3955 (2013.01); A61P 35/00 (2018.01);
Abstract
A method for treating endometrial cancer comprising: administering to a patient a cannabis extract (CE) wherein the cannabis extract comprises cannabidiol (CBD) at between 50% and 99% by weight of the CE.